TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhancing Retention in PMTCT/MNCH Services and Facility Delivery in Tabora, Tanzania
Brief Summary: The goal of this proposed intervention study is to increase the proportion of HIV positive and HIV negative pregnant women who deliver in a facility, the proportion of HIV exposed infants (HEI) who receive nevirapine (NVP) within 48 hours of delivery, and the proportion of HEI who are bled for HIV polymerase chain reaction (PCR) deoxyribonucleic acid (DNA) testing within 8 weeks of age.


Options:
A: Arm Label: Clinic group 1; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth messaging | Arm Label: Clinic group 2; Type: EXPERIMENTAL; Interventions: Behavioral: Transport Payments | Arm Label: Clinic group 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: mHealth messaging; Assigned to Arm(s): Clinic group 1 | Intervention Type: BEHAVIORAL; Name: Transport Payments; Assigned to Arm(s): Clinic group 2
B: Arm Label: Intense follow up; Type: EXPERIMENTAL; Interventions: Behavioral: intense follow up | Arm Label: standard follow-up; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: intense follow up; Assigned to Arm(s): Intense follow up
C: Arm Label: SmartMoms-Clinic; Type: EXPERIMENTAL; Interventions: Behavioral: SmartMoms | Arm Label: SmartMoms-Phone; Type: EXPERIMENTAL; Interventions: Behavioral: SmartMoms | Arm Label: Physician Directed; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SmartMoms; Assigned to Arm(s): SmartMoms-Clinic, SmartMoms-Phone
D: Arm Label: Educational Text Message; Type: EXPERIMENTAL; Interventions: Other: Text Message, Other: Written reminder | Arm Label: Plain Text Message; Type: EXPERIMENTAL; Interventions: Other: Text Message, Other: Written reminder | Arm Label: Written reminder only; Type: OTHER; Interventions: Other: Written reminder | Intervention Type: OTHER; Name: Text Message; Assigned to Arm(s): Educational Text Message, Plain Text Message | Intervention Type: OTHER; Name: Written reminder; Assigned to Arm(s): Educational Text Message, Plain Text Message, Written reminder only

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhancing Retention in PMTCT/MNCH Services and Facility Delivery in Tabora, Tanzania
Brief Summary: The goal of this proposed intervention study is to increase the proportion of HIV positive and HIV negative pregnant women who deliver in a facility, the proportion of HIV exposed infants (HEI) who receive nevirapine (NVP) within 48 hours of delivery, and the proportion of HEI who are bled for HIV polymerase chain reaction (PCR) deoxyribonucleic acid (DNA) testing within 8 weeks of age.


Options:
A: Arm Label: Standard Treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Behavioral: Counseling | Arm Label: Automated Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Other: Smartphone-delivered automated treatment | Intervention Type: BEHAVIORAL; Name: Self-help materials; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: DRUG; Name: nicotine patch; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: BEHAVIORAL; Name: Counseling; Assigned to Arm(s): Standard Treatment | Intervention Type: OTHER; Name: Smartphone-delivered automated treatment; Assigned to Arm(s): Automated Treatment
B: Arm Label: Clinic group 1; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth messaging | Arm Label: Clinic group 2; Type: EXPERIMENTAL; Interventions: Behavioral: Transport Payments | Arm Label: Clinic group 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: mHealth messaging; Assigned to Arm(s): Clinic group 1 | Intervention Type: BEHAVIORAL; Name: Transport Payments; Assigned to Arm(s): Clinic group 2
C: Arm Label: Two-way SMS dialogue; Type: EXPERIMENTAL; Interventions: Behavioral: Two-way SMS Dialogue | Arm Label: One-way SMS Messaging; Type: EXPERIMENTAL; Interventions: Behavioral: One-way SMS Messaging | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Two-way SMS Dialogue; Assigned to Arm(s): Two-way SMS dialogue | Intervention Type: BEHAVIORAL; Name: One-way SMS Messaging; Assigned to Arm(s): One-way SMS Messaging
D: Arm Label: Usual care / opportunistic screening; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Letter and informational sheet; Type: EXPERIMENTAL; Interventions: Other: Letter and informational sheet | Arm Label: Email; Type: EXPERIMENTAL; Interventions: Other: Email | Arm Label: Phone; Type: EXPERIMENTAL; Interventions: Other: Phone | Arm Label: Multimodal; Type: EXPERIMENTAL; Interventions: Other: Multimodal | Intervention Type: OTHER; Name: Letter and informational sheet; Assigned to Arm(s): Letter and informational sheet | Intervention Type: OTHER; Name: Email; Assigned to Arm(s): Email | Intervention Type: OTHER; Name: Phone; Assigned to Arm(s): Phone | Intervention Type: OTHER; Name: Multimodal; Assigned to Arm(s): Multimodal

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Scale Up Evaluation of a Physical Activity Program for Adults With Physical Disability
Brief Summary: The study uses a theory-driven eHealth platform and innovative physical activity (PA) program referred to as movement-to-music (M2M) to deliver a customized, home-based PA intervention for adults with physical disability (PWD). Participants will be recruited through a large physical medicine and rehabilitation network of clinics specializing in treating patients with physical disability. Participants will be randomized to one of three groups: a) M2M; b) M2M plus social networking (M2Mplus); and c) attention control (AC). Participants will be followed for 48 weeks to obtain objective measures on physical activity, fitness and self-reported measures on health at four time points. The study will compare the effectiveness of M2M and M2Mplus in increasing physical activity and adherence compared to the AC group, estimate the improvements in health of M2M and M2Mplus compared to the AC group, and examine the mediators and moderators of the hypothesized treatment effect to understand for whom and how the intervention is effective. This multi-level, scalability study will strengthen our understanding of the potential benefits of eHealth to eliminate barriers to PA participation among PWD.


Options:
A: Arm Label: M2M; Type: EXPERIMENTAL; Interventions: Behavioral: M2M | Arm Label: M2Mplus; Type: EXPERIMENTAL; Interventions: Behavioral: M2M | Arm Label: Attention Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control | Intervention Type: BEHAVIORAL; Name: M2M; Assigned to Arm(s): M2M, M2Mplus | Intervention Type: BEHAVIORAL; Name: Attention Control; Assigned to Arm(s): Attention Control
B: Arm Label: BESMILE-HF group; Type: EXPERIMENTAL; Interventions: Behavioral: BESMILE-HF program, Drug: Usual medications | Arm Label: Control; Type: OTHER; Interventions: Drug: Usual medications | Intervention Type: BEHAVIORAL; Name: BESMILE-HF program; Assigned to Arm(s): BESMILE-HF group | Intervention Type: DRUG; Name: Usual medications; Assigned to Arm(s): BESMILE-HF group, Control
C: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Telehealth Pulmonary Rehabilitation | Intervention Type: OTHER; Name: Telehealth Pulmonary Rehabilitation; Assigned to Arm(s): Intervention
D: Arm Label: AB sequence; Type: EXPERIMENTAL; Interventions: Other: Usual care followed by the use of HeartHab application | Arm Label: BA sequence; Type: EXPERIMENTAL; Interventions: Other: Use of HeartHab application followed by usual care | Intervention Type: OTHER; Name: Use of HeartHab application followed by usual care; Assigned to Arm(s): BA sequence | Intervention Type: OTHER; Name: Usual care followed by the use of HeartHab application; Assigned to Arm(s): AB sequence

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Following Text Message Intervention in Pregnant Women
Brief Summary: The investigators propose an 18-month, randomized, open-label evaluation of the impact of texting to pregnant, underserved, cigarette smokers on smoking cessation rates. Patients will be eligible if they have a confirmed pregnancy, are English speaking, at least 18 years of age, are in the preparation stage of change and willing to set a quit date within 30 days and before 35 weeks gestation, and have a cellular phone that is capable of receiving text messages. Patients will be randomized to either the texting group or control group. A baseline carbon monoxide level will be obtained. The patient, regardless of group, will have the standard of care smoking cessation visit. If the pharmacist, physician, and patient deem that pharmacotherapy is appropriate, patient will receive nicotine replacement therapy patches or bupropion free of charge in 2-week intervals. Patients in the intervention group will receive text messages focused on smoking cessation and pregnancy. Patients will be seen on a bi-weekly schedule to obtain additional vouchers for patches or for bupropion, meet with the pharmacist, and complete a carbon monoxide exhalation test. These visits will be continued until the pharmacotherapy course is complete.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text message; Type: ACTIVE_COMPARATOR; Interventions: Other: SMS reminder message | Arm Label: Text message and voice call; Type: ACTIVE_COMPARATOR; Interventions: Other: Voice call + SMS message | Intervention Type: OTHER; Name: SMS reminder message; Assigned to Arm(s): Text message | Intervention Type: OTHER; Name: Voice call + SMS message; Assigned to Arm(s): Text message and voice call
B: Arm Label: texting group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: text messages focused on smoking cessation and pregnancy | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: text messages focused on smoking cessation and pregnancy; Assigned to Arm(s): texting group
C: Arm Label: Standard of Care (SoC); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SoC + iTab; Type: ACTIVE_COMPARATOR; Interventions: Device: SoC + iTab | Intervention Type: DEVICE; Name: SoC + iTab; Assigned to Arm(s): SoC + iTab
D: Intervention Type: BEHAVIORAL; Name: Pulse; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Following Text Message Intervention in Pregnant Women
Brief Summary: The investigators propose an 18-month, randomized, open-label evaluation of the impact of texting to pregnant, underserved, cigarette smokers on smoking cessation rates. Patients will be eligible if they have a confirmed pregnancy, are English speaking, at least 18 years of age, are in the preparation stage of change and willing to set a quit date within 30 days and before 35 weeks gestation, and have a cellular phone that is capable of receiving text messages. Patients will be randomized to either the texting group or control group. A baseline carbon monoxide level will be obtained. The patient, regardless of group, will have the standard of care smoking cessation visit. If the pharmacist, physician, and patient deem that pharmacotherapy is appropriate, patient will receive nicotine replacement therapy patches or bupropion free of charge in 2-week intervals. Patients in the intervention group will receive text messages focused on smoking cessation and pregnancy. Patients will be seen on a bi-weekly schedule to obtain additional vouchers for patches or for bupropion, meet with the pharmacist, and complete a carbon monoxide exhalation test. These visits will be continued until the pharmacotherapy course is complete.


Options:
A: Arm Label: texting group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: text messages focused on smoking cessation and pregnancy | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: text messages focused on smoking cessation and pregnancy; Assigned to Arm(s): texting group
B: Arm Label: mhealth intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Mhealth intervention | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mhealth intervention; Assigned to Arm(s): mhealth intervention
C: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text Messages; Type: EXPERIMENTAL; Interventions: Other: Daily Text Messages | Intervention Type: OTHER; Name: Daily Text Messages; Assigned to Arm(s): Text Messages
D: Arm Label: SMS Reminder; Type: EXPERIMENTAL; Interventions: Other: SMS Reminder | Arm Label: Interactive Reminder; Type: EXPERIMENTAL; Interventions: Other: Interactive Reminder | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: SMS Reminder; Assigned to Arm(s): SMS Reminder | Intervention Type: OTHER; Name: Interactive Reminder; Assigned to Arm(s): Interactive Reminder

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Following Text Message Intervention in Pregnant Women
Brief Summary: The investigators propose an 18-month, randomized, open-label evaluation of the impact of texting to pregnant, underserved, cigarette smokers on smoking cessation rates. Patients will be eligible if they have a confirmed pregnancy, are English speaking, at least 18 years of age, are in the preparation stage of change and willing to set a quit date within 30 days and before 35 weeks gestation, and have a cellular phone that is capable of receiving text messages. Patients will be randomized to either the texting group or control group. A baseline carbon monoxide level will be obtained. The patient, regardless of group, will have the standard of care smoking cessation visit. If the pharmacist, physician, and patient deem that pharmacotherapy is appropriate, patient will receive nicotine replacement therapy patches or bupropion free of charge in 2-week intervals. Patients in the intervention group will receive text messages focused on smoking cessation and pregnancy. Patients will be seen on a bi-weekly schedule to obtain additional vouchers for patches or for bupropion, meet with the pharmacist, and complete a carbon monoxide exhalation test. These visits will be continued until the pharmacotherapy course is complete.


Options:
A: Arm Label: Text and Voice Messages; Type: EXPERIMENTAL; Interventions: Behavioral: Text and Voice Messages | Arm Label: Interactive Phone Call; Type: EXPERIMENTAL; Interventions: Behavioral: Interactive Phone Call | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text and Voice Messages; Assigned to Arm(s): Text and Voice Messages | Intervention Type: BEHAVIORAL; Name: Interactive Phone Call; Assigned to Arm(s): Interactive Phone Call
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text message; Type: ACTIVE_COMPARATOR; Interventions: Other: SMS reminder message | Arm Label: Text message and voice call; Type: ACTIVE_COMPARATOR; Interventions: Other: Voice call + SMS message | Intervention Type: OTHER; Name: SMS reminder message; Assigned to Arm(s): Text message | Intervention Type: OTHER; Name: Voice call + SMS message; Assigned to Arm(s): Text message and voice call
C: Arm Label: texting group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: text messages focused on smoking cessation and pregnancy | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: text messages focused on smoking cessation and pregnancy; Assigned to Arm(s): texting group
D: Arm Label: SMS Vaccine; Type: N/A; Interventions: Behavioral: SMS message reminding mothers to come for their scheduled vaccines | Arm Label: Usual care; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SMS message reminding mothers to come for their scheduled vaccines; Assigned to Arm(s): SMS Vaccine

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Following Text Message Intervention in Pregnant Women
Brief Summary: The investigators propose an 18-month, randomized, open-label evaluation of the impact of texting to pregnant, underserved, cigarette smokers on smoking cessation rates. Patients will be eligible if they have a confirmed pregnancy, are English speaking, at least 18 years of age, are in the preparation stage of change and willing to set a quit date within 30 days and before 35 weeks gestation, and have a cellular phone that is capable of receiving text messages. Patients will be randomized to either the texting group or control group. A baseline carbon monoxide level will be obtained. The patient, regardless of group, will have the standard of care smoking cessation visit. If the pharmacist, physician, and patient deem that pharmacotherapy is appropriate, patient will receive nicotine replacement therapy patches or bupropion free of charge in 2-week intervals. Patients in the intervention group will receive text messages focused on smoking cessation and pregnancy. Patients will be seen on a bi-weekly schedule to obtain additional vouchers for patches or for bupropion, meet with the pharmacist, and complete a carbon monoxide exhalation test. These visits will be continued until the pharmacotherapy course is complete.


Options:
A: Arm Label: Two-way SMS dialogue; Type: EXPERIMENTAL; Interventions: Behavioral: Two-way SMS Dialogue | Arm Label: One-way SMS Messaging; Type: EXPERIMENTAL; Interventions: Behavioral: One-way SMS Messaging | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Two-way SMS Dialogue; Assigned to Arm(s): Two-way SMS dialogue | Intervention Type: BEHAVIORAL; Name: One-way SMS Messaging; Assigned to Arm(s): One-way SMS Messaging
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Voice Reminder (Group A); Type: EXPERIMENTAL; Interventions: Behavioral: Voice Reminder (Group A) | Arm Label: Cash Incentive (Group B); Type: EXPERIMENTAL; Interventions: Behavioral: Cash Incentive (Group B) | Intervention Type: BEHAVIORAL; Name: Voice Reminder (Group A); Assigned to Arm(s): Voice Reminder (Group A) | Intervention Type: BEHAVIORAL; Name: Cash Incentive (Group B); Assigned to Arm(s): Cash Incentive (Group B)
C: Arm Label: texting group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: text messages focused on smoking cessation and pregnancy | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: text messages focused on smoking cessation and pregnancy; Assigned to Arm(s): texting group
D: Arm Label: LATCH Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: LATCH Intervention | Intervention Type: BEHAVIORAL; Name: LATCH Intervention; Assigned to Arm(s): LATCH Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Following Text Message Intervention in Pregnant Women
Brief Summary: The investigators propose an 18-month, randomized, open-label evaluation of the impact of texting to pregnant, underserved, cigarette smokers on smoking cessation rates. Patients will be eligible if they have a confirmed pregnancy, are English speaking, at least 18 years of age, are in the preparation stage of change and willing to set a quit date within 30 days and before 35 weeks gestation, and have a cellular phone that is capable of receiving text messages. Patients will be randomized to either the texting group or control group. A baseline carbon monoxide level will be obtained. The patient, regardless of group, will have the standard of care smoking cessation visit. If the pharmacist, physician, and patient deem that pharmacotherapy is appropriate, patient will receive nicotine replacement therapy patches or bupropion free of charge in 2-week intervals. Patients in the intervention group will receive text messages focused on smoking cessation and pregnancy. Patients will be seen on a bi-weekly schedule to obtain additional vouchers for patches or for bupropion, meet with the pharmacist, and complete a carbon monoxide exhalation test. These visits will be continued until the pharmacotherapy course is complete.


Options:
A: Arm Label: texting group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: text messages focused on smoking cessation and pregnancy | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: text messages focused on smoking cessation and pregnancy; Assigned to Arm(s): texting group
B: Arm Label: Wired mothers intervention; Type: EXPERIMENTAL; Interventions: Device: Wired mothers | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Wired mothers; Assigned to Arm(s): Wired mothers intervention
C: Arm Label: Smartphone-enabled app for linkage to care; Type: EXPERIMENTAL; Interventions: Other: Smartphone application, Device: Smartphone | Arm Label: Standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Smartphone application; Assigned to Arm(s): Smartphone-enabled app for linkage to care | Intervention Type: DEVICE; Name: Smartphone; Assigned to Arm(s): Smartphone-enabled app for linkage to care
D: Arm Label: cMM and Text Messaging; Type: OTHER; Interventions: Behavioral: cMM, Behavioral: Text Messaging | Arm Label: cMM Only; Type: OTHER; Interventions: Behavioral: cMM | Arm Label: Text Messaging Only; Type: OTHER; Interventions: Behavioral: Text Messaging | Arm Label: Neither cMM nor Text Messaging; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: cMM; Assigned to Arm(s): cMM Only, cMM and Text Messaging | Intervention Type: BEHAVIORAL; Name: Text Messaging; Assigned to Arm(s): Text Messaging Only, cMM and Text Messaging

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of the Oral Stimulation Program in Extreme Preterm Infants: A Randomized Clinical Trial
Brief Summary: The purpose of this study is to determine whether oral stimulation program are effective to improve oral feeding efficiency. The sample size estimated in 74 preterm, randomized classification of the subjects into to experimental and a control group.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Intervention group | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Other: Control group | Intervention Type: OTHER; Name: Intervention group; Assigned to Arm(s): Intervention group | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): Control group
B: Arm Label: EPI experimental; Type: EXPERIMENTAL; Interventions: Device: NTrainer | Arm Label: EPI control; Type: SHAM_COMPARATOR; Interventions: Device: SHAM blind pacifier | Intervention Type: DEVICE; Name: NTrainer; Assigned to Arm(s): EPI experimental | Intervention Type: DEVICE; Name: SHAM blind pacifier; Assigned to Arm(s): EPI control
C: Intervention Type: DEVICE; Name: partial-vacuum milk bottle; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: anti-vacuum milk bottle; Assigned to Arm(s): N/A
D: Arm Label: skin to skin contact; Type: EXPERIMENTAL; Interventions: Other: skin to skin contact | Arm Label: Control group; Type: EXPERIMENTAL; Interventions: Other: Control group | Intervention Type: OTHER; Name: skin to skin contact; Assigned to Arm(s): skin to skin contact | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): Control group

Answer: A